Medical Oncologist

Vice Chair for Research, Department of Neurology; Evnin Family Chair in Neuro-Oncology

Pictured: Ingo Mellinghoff

About Me

I am a medical oncologist who specializes in the treatment of primary brain tumors. My laboratory studies signal transduction abnormalities in glioblastoma which might be targeted with new cancer therapeutics.

Read more
  • Clinical Expertise: Primary Brain Tumors
  • Languages Spoken: English
  • Education: MD, Technische Universitat Munchen
  • Residencies: Internal Medicine - University of California Los Angeles
  • Fellowships: Hematology/Oncology - University of California Los Angeles
  • Board Certifications: Internal Medicine; Medical Oncology; Hematology

My Research

View my lab

See Ingo K. Mellinghoff’s laboratory
research at Memorial Sloan Kettering.

See My Colleagues


Visit PubMed for a full listing of Ingo K. Mellinghoff’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more